GSK sells worldwide rights for linerixibat to Alfasigma for $300m



[
GSK sells worldwide rights for linerixibat to Alfasigma for $300m
[og_img]
https://www.investing.com/news/stock-market-news/gsk-sells-worldwide-rights-for-linerixibat-to-alfasigma-for-300m-93CH-4548764


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img